Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases

Abstract

Adenosine is involved in a range of physiological and pathological effects through membrane-bound receptors linked to G proteins. There are four subtypes of adenosine receptors, described as A ₁AR, A _2AAR, A _2BAR, and A ₃AR, which are the center of cAMP signal pathway-based drug development. Several types of agonists, partial agonists or antagonists, and allosteric substances have been synthesized from these receptors as new therapeutic drug candidates. Research efforts surrounding A ₁AR and A _2AAR are perhaps the most enticing because of their concentration and affinity; however, as a consequence of distressing conditions, both A _2BAR and A ₃AR levels might accumulate. This review focuses on the biological features of each adenosine receptor as the basis of ligand production and describes clinical studies of adenosine receptor-associated pharmaceuticals in human diseases.